Emergent BioSolutions
Focus: Emergent BioSolutions is a CDMO and specialty pharmaceutical company headquartered in Winnipeg, focused on biologics manufacturing, contract manufacturing, and biodefense solutions across infectious diseases, vaccines, oncology, and immunology.
Profile data last refreshed 22h ago · AI intelligence enriched 5d ago
Open Jobs
0
About Emergent BioSolutions
AI assessmentNot HiringNo open roles listed right now. Follow Emergent BioSolutions to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Emergent BioSolutions's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$107M Part DDeclining
LOE Approaching
Anchor revenue source representing 100% of company revenue, but approaching loss of exclusivity with minimal replacement pipeline in commercial stage.
Help build intelligence for Emergent BioSolutions
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.